Walczak H - Search Results

1

Following TRAIL's path in the immune system.

Falschlehner C, Schaefer U, Walczak H. Falschlehner C, et al. Among authors: walczak h. Immunology. 2009 Jun;127(2):145-54. doi: 10.1111/j.1365-2567.2009.03058.x. Immunology. 2009. PMID: 19476510 Free PMC article. Review.

2

Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha.

Shinbori T, Walczak H, Krammer PH. Shinbori T, et al. Among authors: walczak h. Eur J Immunol. 2004 Jun;34(6):1762-70. doi: 10.1002/eji.200425097. Eur J Immunol. 2004. PMID: 15162447 Free article.

3

TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy.

Wissink EH, Verbrugge I, Vink SR, Schader MB, Schaefer U, Walczak H, Borst J, Verheij M. Wissink EH, et al. Among authors: walczak h. Radiother Oncol. 2006 Aug;80(2):214-22. doi: 10.1016/j.radonc.2006.07.030. Epub 2006 Aug 17. Radiother Oncol. 2006. PMID: 16916556

4

TRAIL signalling: decisions between life and death.

Falschlehner C, Emmerich CH, Gerlach B, Walczak H. Falschlehner C, et al. Among authors: walczak h. Int J Biochem Cell Biol. 2007;39(7-8):1462-75. doi: 10.1016/j.biocel.2007.02.007. Epub 2007 Feb 14. Int J Biochem Cell Biol. 2007. PMID: 17403612 Review.

5

TRAIL: a multifunctional cytokine.

Schaefer U, Voloshanenko O, Willen D, Walczak H. Schaefer U, et al. Among authors: walczak h. Front Biosci. 2007 May 1;12:3813-24. doi: 10.2741/2354. Front Biosci. 2007. PMID: 17485341 Review.

6

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

Grosse-Wilde A, Voloshanenko O, Bailey SL, Longton GM, Schaefer U, Csernok AI, Schütz G, Greiner EF, Kemp CJ, Walczak H. Grosse-Wilde A, et al. Among authors: walczak h. J Clin Invest. 2008 Jan;118(1):100-10. doi: 10.1172/JCI33061. J Clin Invest. 2008. PMID: 18079967 Free PMC article.

7

From biochemical principles of apoptosis induction by TRAIL to application in tumour therapy.

Cordier SM, Papenfuss K, Walczak H. Cordier SM, et al. Among authors: walczak h. Results Probl Cell Differ. 2009;49:115-43. doi: 10.1007/400_2008_27. Results Probl Cell Differ. 2009. PMID: 19142621 Review.

8

Is TRAIL the holy grail of cancer therapy?

Newsom-Davis T, Prieske S, Walczak H. Newsom-Davis T, et al. Among authors: walczak h. Apoptosis. 2009 Apr;14(4):607-23. doi: 10.1007/s10495-009-0321-2. Apoptosis. 2009. PMID: 19194800 Review.

9

TRAIL and other TRAIL receptor agonists as novel cancer therapeutics.

Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H. Falschlehner C, et al. Among authors: walczak h. Adv Exp Med Biol. 2009;647:195-206. doi: 10.1007/978-0-387-89520-8_14. Adv Exp Med Biol. 2009. PMID: 19760076 Review.

10

Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells.

Hoogwater FJ, Nijkamp MW, Smakman N, Steller EJ, Emmink BL, Westendorp BF, Raats DA, Sprick MR, Schaefer U, Van Houdt WJ, De Bruijn MT, Schackmann RC, Derksen PW, Medema JP, Walczak H, Borel Rinkes IH, Kranenburg O. Hoogwater FJ, et al. Among authors: walczak h. Gastroenterology. 2010 Jun;138(7):2357-67. doi: 10.1053/j.gastro.2010.02.046. Epub 2010 Feb 23. Gastroenterology. 2010. PMID: 20188103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page